These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27333191)

  • 1. Fragile X syndrome screening in pregnant women and women planning pregnancy shows a remarkably high FMR1 premutation prevalence in the Balearic Islands.
    Alfaro Arenas R; Rosell Andreo J; Heine Suñer D;
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1023-1031. PubMed ID: 27333191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Characterization of FMR1 Gene by TP-PCR in Women of Reproductive Age and Women with Premature Ovarian Insufficiency.
    Dean DD; Agarwal S; Kapoor D; Singh K; Vati C
    Mol Diagn Ther; 2018 Feb; 22(1):91-100. PubMed ID: 29188551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Assays for AGG Interruptions in Fragile X Premutation Carriers.
    Hayward BE; Usdin K
    J Mol Diagn; 2017 Nov; 19(6):828-835. PubMed ID: 28818679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of screening strategies for fragile X syndrome in the UK.
    Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G
    Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Cryptic Fragile X Full Mutation Alleles by Southern Blot in a Female and Her Foetal DNA via Chorionic Villus Sampling, Complicated by Mosaicism for 45,X0/46,XX/47,XXX.
    Pandelache A; Francis D; Oertel R; Dickson R; Sachdev R; Ling L; Gamage D; Godler DE
    Genes (Basel); 2021 May; 12(6):. PubMed ID: 34073864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining reproductive risk for FMR1 premutation carriers in the general obstetric population.
    Owens KM; Terhaar C; Zdrodowski J; Johnson LR; Eveleigh D
    Am J Med Genet A; 2022 May; 188(5):1476-1481. PubMed ID: 35129870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the human fragile X mental retardation 1 polymerase chain reaction reagents to amplify the FMR1 gene: testing in a clinical diagnostic laboratory.
    Nahhas FA; Monroe TJ; Prior TW; Botma PI; Fang J; Snyder PJ; Talbott SL; Feldman GL
    Genet Test Mol Biomarkers; 2012 Mar; 16(3):187-92. PubMed ID: 21992462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular screening of intellectually disabled patients and those with premature ovarian failure for CGG repeat expansion at FMR1 locus: Implication of combined triplet repeat primed polymerase chain reaction and methylation-specific polymerase chain reaction analysis.
    Muthuswamy S; Dean DD; Agarwal S
    Neurol India; 2016; 64(6):1175-1179. PubMed ID: 27841182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis.
    Cheng YK; Lin CS; Kwok YK; Chan YM; Lau TK; Leung TY; Choy KW
    Hong Kong Med J; 2017 Apr; 23(2):110-6. PubMed ID: 28253484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot fragile X screening in normal population of Taiwan.
    Tzeng CC; Cho WC; Kuo PL; Chen RM
    Diagn Mol Pathol; 1999 Sep; 8(3):152-6. PubMed ID: 10565687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel.
    Toledano-Alhadef H; Basel-Vanagaite L; Magal N; Davidov B; Ehrlich S; Drasinover V; Taub E; Halpern GJ; Ginott N; Shohat M
    Am J Hum Genet; 2001 Aug; 69(2):351-60. PubMed ID: 11443541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced technologies for the molecular diagnosis of fragile X syndrome.
    Tassone F
    Expert Rev Mol Diagn; 2015; 15(11):1465-73. PubMed ID: 26489042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of AGG interruptions in the transcription of FMR1 premutation alleles.
    Yrigollen CM; Tassone F; Durbin-Johnson B; Tassone F
    PLoS One; 2011; 6(7):e21728. PubMed ID: 21818263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the clinical utility of a long-read sequencing-based approach in genetic testing of fragile-X syndrome.
    Hou F; Mao A; Shan S; Li Y; Meng W; Zhan J; Nie W; Jin H
    Clin Chim Acta; 2023 Nov; 551():117614. PubMed ID: 38375623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal FMR1 alleles expansion in newborns during transmission: a prospective cohort study.
    Shahid R; Yasin M; Rehman ZU; Jadoon H; Tahir H; Meraj N; Khan N; Zubair M; Zulfiqar I; Nowshid M; Azeem A; Jabeen M; Hameed A; Saleha S
    Pediatr Res; 2023 Feb; 93(3):720-724. PubMed ID: 35681093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragile X analysis of 1112 prenatal samples from 1991 to 2010.
    Nolin SL; Glicksman A; Ding X; Ersalesi N; Brown WT; Sherman SL; Dobkin C
    Prenat Diagn; 2011 Oct; 31(10):925-31. PubMed ID: 21717484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal FMR1 premutation allele expansion and contraction in fraternal twins.
    Alfaro MP; Cohen M; Vnencak-Jones CL
    Am J Med Genet A; 2013 Oct; 161A(10):2620-5. PubMed ID: 23949867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Chinese genetic reference panel for Fragile X Syndrome and its application to the screen of 10,000 Chinese pregnant women and women planning pregnancy.
    Gao F; Huang W; You Y; Huang J; Zhao J; Xue J; Kang H; Zhu Y; Hu Z; Allen EG; Jin P; Xia K; Duan R
    Mol Genet Genomic Med; 2020 Jun; 8(6):e1236. PubMed ID: 32281281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both cis and trans-acting genetic factors drive somatic instability in female carriers of the FMR1 premutation.
    Hwang YH; Hayward BE; Zafarullah M; Kumar J; Durbin Johnson B; Holmans P; Usdin K; Tassone F
    Sci Rep; 2022 Jun; 12(1):10419. PubMed ID: 35729184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragile X full mutation expansions are inhibited by one or more AGG interruptions in premutation carriers.
    Nolin SL; Glicksman A; Ersalesi N; Dobkin C; Brown WT; Cao R; Blatt E; Sah S; Latham GJ; Hadd AG
    Genet Med; 2015 May; 17(5):358-64. PubMed ID: 25210937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.